These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24942477)

  • 1. Molecular imaging in acromegaly: should clinicians look carefully at developments in the field?
    Giustina A; Mazziotti G; Giubbini R
    Nucl Med Commun; 2014 Sep; 35(9):897-9. PubMed ID: 24942477
    [No Abstract]   [Full Text] [Related]  

  • 2. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possibilities of using molecular imaging methods with complex modern radiopharmaceuticals in neurooncology].
    Tiutin LA; Stanzhevskiĭ AA; Panfilenko AF; Kostenikov NA; Iliushchenko IuR
    Vopr Onkol; 2013; 59(4):421-7. PubMed ID: 24032214
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical usefulness of coregistered 11C-methionine positron emission tomography/3-T magnetic resonance imaging at the follow-up of acromegaly.
    Rodriguez-Barcelo S; Gutierrez-Cardo A; Dominguez-Paez M; Medina-Imbroda J; Romero-Moreno L; Arraez-Sanchez M
    World Neurosurg; 2014; 82(3-4):468-73. PubMed ID: 24239736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorodeoxyglucose uptake predicts survival in a CT screening trial.
    Erasmus JJ
    J Thorac Oncol; 2009 Nov; 4(11):1305-6. PubMed ID: 19861902
    [No Abstract]   [Full Text] [Related]  

  • 7. Unusual loss of FDG uptake in recurrent GIST.
    Dunzinger A; Decker J; Kieberger A; Weis S; Pichler R
    Nuklearmedizin; 2014 Aug; 53(4):N35-7. PubMed ID: 25100559
    [No Abstract]   [Full Text] [Related]  

  • 8. Sweet clarity: less invasive measures of hepatic glucose metabolism.
    Fine EJ; Lee DE; Hawkins M
    Gastroenterology; 2007 Feb; 132(2):794-7. PubMed ID: 17261305
    [No Abstract]   [Full Text] [Related]  

  • 9. Normal variants in [18F]-fluorodeoxyglucose PET imaging.
    El-Haddad G; Alavi A; Mavi A; Bural G; Zhuang H
    Radiol Clin North Am; 2004 Nov; 42(6):1063-81, viii. PubMed ID: 15488558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glucose uptake by keratoacanthoma detected by positron emission tomography.
    Kanekura T; Yonekura K; Yoshii N
    Clin Exp Dermatol; 2007 Sep; 32(5):581-2. PubMed ID: 17509063
    [No Abstract]   [Full Text] [Related]  

  • 11. Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography.
    Macmanus MP; Hicks RJ
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):2-4. PubMed ID: 18406881
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic response evaluation by nuclear functional imaging].
    Moretti JL; Hindie E; Vercellino L
    Bull Cancer; 2007; 94(7 Suppl):F241-4. PubMed ID: 17965003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Listen to your belly, fat is not your foe!
    Kotzerke J; Zöphel K
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):108-109. PubMed ID: 27734119
    [No Abstract]   [Full Text] [Related]  

  • 14. Heavy PETting: reducing radiation exposure from intradepartment positron emission tomography scans.
    Bornstein S; Young K; Tanyi J; Holland J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):545. PubMed ID: 24368063
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic evidence of myocardial stunning in takotsubo cardiomyopathy: a positron emission tomography study.
    Obunai K; Misra D; Van Tosh A; Bergmann SR
    J Nucl Cardiol; 2005; 12(6):742-4. PubMed ID: 16344237
    [No Abstract]   [Full Text] [Related]  

  • 16. Benign uterine uptake of FDG: a case report and review of literature.
    Vriens D; de Geus-Oei LF; Flucke UE; van der Kogel AJ; Oyen WJ; Vierhout ME; van der Meer JW
    Neth J Med; 2010 Sep; 68(9):379-80. PubMed ID: 20876921
    [No Abstract]   [Full Text] [Related]  

  • 17. 18F-fluorodeoxyglucose uptake and apparent diffusion coefficient in lung schwannoma.
    Ushiyama T; Katsuda E; Tanaka M; Numanami H; Takahashi E; Baba K; Yamaguchi E; Yokoi T; Haniuda M; Kubo A
    Clin Imaging; 2012; 36(1):65-7. PubMed ID: 22226446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging in Acute Aortic Syndrome: Lighting a Path to Better Risk Assessment.
    Tawakol A; Mezue KN
    JACC Cardiovasc Imaging; 2022 Jul; 15(7):1305-1307. PubMed ID: 35798406
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography.
    Obando JA; Samii JM; Yasrebi M
    Clin Nucl Med; 2008 Nov; 33(11):775-7. PubMed ID: 18936611
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidental thyroidal tracer uptake [corrected] during [18F]-fluorodeoxyglucose positron emission tomography].
    Müssig K; Oksüz MO
    Dtsch Med Wochenschr; 2009 Jul; 134(31-32):1585-6. PubMed ID: 19629923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.